Toumy Guettouche
@ToumyGG
Followers
238
Following
1K
Statuses
890
Omics enthusiast. Opinions are my own. 🇩🇪⚽️⚪️🔴🐊
Boston, MA
Joined October 2012
@GenomicsCow lol I was thinking how did they come up with this name and came to the conclusion I that they “borrowed” part of the name from a larger company that was a former employer.
0
0
0
Below is a presentation by Sally J. Rockey, at the time NIH Deputy Director of Extramural Research, where she explains how IDC rates are set and what they fund.
0
1
4
@GenomicsCow That’s the connection. But where did the -lent come from? Not exactly a typical part of a Biotech company name.
1
0
0
@prmshra My experience is different. A startup has to be nimble and react to changes in the market or regulation. This means plans made a month ago may have to change. The challenge is to realize when that point is reached. And of course the other challenge is not to be a squirrel.
0
0
0
@sinabooeshaghi Great thread. Fewer young faculty hires with less or no startup package. This will make US academia a lot less attractive.
0
0
1
@CMichaelGibson @zeynep This will especially affect young investigators that do not have an RO1 yet. They usually get starter packages that helps them to bridge the gap until they get their own funding.
0
0
1
@florian_krammer Are you sure it’s still 100% max? In any case, at 15% I think the impact on any institution that has a serious NIH grant footprint will be significant. Especially if this happens immediately.
0
0
0
If this policy stays in place, the ripple effects will be far reaching.
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
0
0
1
@GenomicsCow When your legal team thinks they can predict world politics. Playing checkers but think they are playing chess.
0
0
1
@DrBPHealth Again, valid points. Larger meta studies are trying to control for the major confounders. The data on this confounders may also be flawed. Red meat consumed today is different from red meat from ancient times. And mechanistic molecular data supports my point.
0
0
0
@DrBPHealth Here is a recent meta analysis that supports the view that red mead consumption is an important risk factor.
0
0
0
@DrBPHealth The evidence is mounting, but if you find high quality studies to debunk this, then go ahead. Looking forward to see the post.
1
0
0